MOST POPULAR
Interferon-β for Treatment of COVID-19: Subcutaneous Administration more Effective
Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
E‐Tattoo to Monitor Blood Pressure Continuously
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Story of Coronaviruses: How the ‘’novel Coronavirus (SARS-CoV-2)’’ May Have Emerged?
Coronaviruses are not new; these are as old as anything in the world and are known to cause common cold among humans for ages....
Dog: Man’s Best Companion
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
PHILIP: Laser-Powered Rover to Explore Super-Cold Lunar Craters for Water
Though data from orbiters have suggested presence of water ice, the exploration of lunar craters in the polar regions of moon has not been...
Videos
LATEST ARTICLES
Asciminib (Scemblix) for Newly Diagnosed Chronic Myeloid Leukemia (CML)
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
Particle colliders for study of “Very early universe”: Muon collider demonstrated
Particle accelerators are used as research tools for the study of very early universe. Hadron colliders (particularly CERN’s Large Hadron Collider LHC) and electron-positron...
De-extinction and Species preservation: New milestones for resurrection of Thylacine (Tasmanian...
The thylacine de-extinction project announced in 2022 has achieved new milestones in generation of the highest quality ancient genome, marsupial genome editing and new...
Search of Life Beyond Earth: Clipper Mission to Europa Launched
NASA has successfully launched Clipper mission to Europa into space on Monday 14 October 2024. Two-way communication has been established with the spacecraft since...
Hympavzi (marstacimab): New Treatment for Hemophilia
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
2024 Nobel in Chemistry for “Designing protein” and “Predicting protein structure”...
One half of the Nobel Prize in Chemistry 2024 has been awarded to David Baker “for computational protein design”. The other half has been...